Ignite Creation Date:
2024-05-06 @ 6:56 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05835934
Status:
COMPLETED
Last Update Posted:
2023-04-28
First Post:
2023-04-19
Brief Title:
Pharmacokinetics Mass Balance and Metabolism of 14CHSK21542 in Healthy Adult Male Volunteers
Sponsor:
Haisco Pharmaceutical Group Co Ltd
Organization:
Haisco Pharmaceutical Group Co Ltd
Study Overview
Official Title:
A Phase I Clinical Study on Absorption Metabolism and Excretion of 14CHSK21542 in Healthy Adult Male Chinese Subjects - Mass Balance and Biotransformation of 14CHSK21542 in Human
Status:
COMPLETED
Status Verified Date:
2023-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a single-center nonrandomized and open design study to investigate the pharmacokinetics mass balance metabolism and excretion of HSK21542 in healthy male subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None